Atria Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,499
| Closed | -$370K | – | 1911 |
|
|
2024
Q2 | $370K | Buy |
+4,499
| New | +$370K | ﹤0.01% | 1461 |
|
|
2020
Q3 | – | Sell |
-9,545
| Closed | -$1.18M | – | 583 |
|
|
2020
Q2 | $1.18M | Buy |
9,545
+629
| +7% | +$77.6K | 0.04% | 462 |
|
|
2020
Q1 | $753K | Buy |
8,916
+3,286
| +58% | +$278K | 0.06% | 271 |
|
|
2019
Q4 | $476K | Buy |
5,630
+2,614
| +87% | +$221K | 0.01% | 803 |
|
|
2019
Q3 | $203K | Sell |
3,016
-359
| -11% | -$24.2K | 0.01% | 846 |
|
|
2019
Q2 | $243K | Buy |
3,375
+660
| +24% | +$47.5K | 0.01% | 822 |
|
|
2019
Q1 | $241K | Sell |
2,715
-246
| -8% | -$21.8K | 0.01% | 793 |
|
|
2018
Q4 | $252K | Sell |
2,961
-297
| -9% | -$25.3K | 0.01% | 719 |
|
|
2018
Q3 | $316K | Buy |
3,258
+317
| +11% | +$30.7K | 0.01% | 754 |
|
|
2018
Q2 | $277K | Buy |
+2,941
| New | +$277K | 0.01% | 762 |
|